EPISODE · Dec 6, 2021 · 32 MIN
What is the Real Cost of Developing Medicine?
from Healthcare Americana
Panna Sharma, CEO of Lantern Pharma, discusses how his company is bringing cancer therapies to the market faster, cheaper and at a lower cost than other biotechs through artificial intelligence, machine learning and genomic data. He emphasizes that it shouldn’t cost $2 billion to make medicine. He shares it costs this much because Big Pharma is artificially inflating pricing. Lantern Pharma is changing healthcare because it is developing new medicines significantly cheaper than big pharma, in a time frame that is unheard of, with only a dozen people.Support the show (https://healthcareamericana.com/sponsors/)
What this episode covers
Panna Sharma, CEO of Lantern Pharma, discusses how his company is bringing cancer therapies to the market faster, cheaper and at a lower cost than other biotechs through artificial intelligence, machine learning and genomic data. He emphasizes that it shouldn’t cost $2 billion to make medicine. He shares it costs this much because Big Pharma is artificially inflating pricing. Lantern Pharma is changing healthcare because it is developing new medicines significantly cheaper than big pharma, in a time frame that is unheard of, with only a dozen people.Support the show (https://healthcareamericana.com/sponsors/)
NOW PLAYING
What is the Real Cost of Developing Medicine?
No transcript for this episode yet
Similar Episodes
No similar episodes found.